Abstract:Purpose: To quantify interfractional anatomical variations and their dosimetric impact during the course of fractionated proton therapy (PT) of prostate cancer and to assess the robustness of the current treatment planning techniques.Methods: Simulation and daily in-room CT scans from ten prostate carcinoma patients were analyzed. PT treatment plans (78 Gy in 39 fractions of 2 Gy) were created on the simulation CT, delivering 25 fractions to PTV1 (expanded from prostate and seminal vesicles), followed by 14 boost fractions to PTV2 (expanded from prostate). Plans were subsequently applied to daily CT, with beams aligned to the prostate center in the sagittal plane. For five patients having a sufficiently large daily imaging volume, structure contours were manually drawn, and plans were evaluated for all CT sets. For the other five patients, the plans were evaluated for six selected fractions. The daily CT was matched to the simulation CT through deformable registration. The registration accuracy was validated for each fraction, and the three patients with a large number of accurately registered fractions were used for dose accumulation.Results: In individual fractions, the coverage of the prostate, seminal vesicles, and PTV1 was generally maintained at the corresponding prescription dose. For PTV2, the volume covered by the fractional prescription dose of 2 Gy (i.e., V2) was, on average, reduced by less than 3% compared to the simulation plan. Among the 225 (39 x 5 + 6 x 5) fractions examined, 15 showed a V2 reduction larger than 5%, of which ten were caused by a large variation in rectal gas, and five were due to a prostate shift in the craniocaudal direction. The fractional dose to the anterior rectal wall was found to increase for one patient who had large rectal gas volume in 25 of the 39 fractions, and another who experienced significant prostate volume reduction during the treatment. The fractional bladder dose generally increased with decreasing fullness. In the total accumulated dose for the three patients after excluding a few fractions with inaccurate registration due to a large amount of rectal gas (a condition inconsistent with RTOG protocol), 98.5%, 96.6%, and 98.2% of the PTV2 received the prescription dose of 78 Gy. The V75 and V70 of the anterior rectal wall and bladder both remained within tolerance.Conclusions: The results confirm that the PT planning techniques and dose constraints used at our institution ensure that target coverage to the prescription dose is maintained in the presence of interfractional anatomical variations. Dose coverage in individual fractions can be compromised, and normal tissue dose increased, due to deviations in the bladder and rectal volume compared to the simulation plans or progressive changes in the prostate volume during the treatment. Deviations from the plan can be reduced with efforts aimed at maintaining consistent daily patient anatomy. (C) 2011 American Association of Physicists in Medicine. [DOI: 10.1118/1.3604152]

Dosimetric Effects of Anatomical Changes for Abdominal Organs at Risk During the Course of Hypofractionated Radiation Therapy in Pancreatic Cancer Patients

Predictive Dosimetric Parameters for Gastrointestinal Toxicity in Pancreatic Adenocarcinoma with Hypofractioned Radiation Therapy

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

Characterization and Management of Interfractional Anatomic Changes for Pancreatic Cancer Radiotherapy

Dose Evaluations of Organs at Risk and Predictions of Gastrointestinal Toxicity after Re-Irradiation with Stereotactic Body Radiation Therapy for Pancreatic Cancer by Deformable Image Registration

Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer

Evaluation of pancreatic subclinical dysfunction and sparing of pancreas after intensity-modulated radiation therapy for gastric cancer

Two Courses Of Stereotactic Body Radiation Therapy For Patients With Pancreatic Cancer: Dose And Toxicity

Effect of High-Dose and Hypofractionated Radiation Therapy for Immunological Parameters in Pancreatic Cancer

Dosimetric Comparison of Different Pattern of Intensity-modulated Radiotherapy for Pancreatic Carcinoma

Dosimetric Benefit Of Adaptive Re-Planning In Pancreatic Cancer Stereotactic Body Radiotherapy

Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy

Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma

A Preferred Patient Decubitus Positioning for Magnetic Resonance Image Guided Online Adaptive Radiation Therapy of Pancreatic Cancer

Influence of Position and Radiation Technique on Organs at Risk in Radiotherapy of Rectal Cancer.

Effects of Bladder and Rectum Management on Dose Distributions of Target and Organs at Risk in Intensity-Modulated Radiotherapy for Prostate Cancer

Planning Target Volume Margin Definition from Image Guided Hypofractionated Radiation Therapy for Pancreatic Cancer

Characterizing Compromised Target Coverage With Hypofractionated Radiation Therapy for Pancreatic Cancer

SU‐E‐T‐334: Dosimetric Impacts of Organ at Risk (OAR) Contour Errors in Prostate Volumetric Modulated Arc Therapy (VMAT) Planning: A Sensitivity Study

Pilot Study Of Hypofractionated Radiation Therapy For Locally Advanced And Metastatic Pancreatic Cancer